RXi Pharma makes $12 million equity offering
This article was originally published in Scrip
Executive Summary
The RNAi company RXi Pharmaceuticals has given details of a public stock and warrant offering of 12 million units, and proposes to raise $12 million. Roth Capital Partners is the sole manager.